Physician profile
Daniel Diaco
NPI 1013074459
$7,123.59
in general payments reported to CMS, 2019-2025
9 companies · $342 in 2025
The $342 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,108 · 2020: $868 · 2021: $1,154 · 2022: $395 · 2023: $2,140 · 2024: $117 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,492 · Food and Beverage: $1,107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,491.62 |
| Food and Beverage | $1,106.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,234.88 | 2019-2022 | |
| Abbvie INC. | $1,989.96 | 2023-2024 | Natrelle Saline-Filled Breast Implants, Strattice Reconstructive Tissue Matrix Bps |
| Mentor Worldwide LLC | $1,151.61 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Sientra, INC. | $1,049.58 | 2020-2021 | |
| Lumenis Be INC | $283.10 | 2025 | M22 |
| Tepha INC | $152.19 | 2020 | |
| Kci USA, INC. | $130.20 | 2020 | |
| Solta Medical, A Division of Bausch Health US, LLC | $102.51 | 2022 | |
| Galderma Laboratories, L.P. | $29.56 | 2019-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Diaco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.